Legal & General Group Plc Purchases Shares of 45,097 Addus HomeCare Corporation $ADUS

Legal & General Group Plc purchased a new stake in shares of Addus HomeCare Corporation (NASDAQ:ADUS) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 45,097 shares of the company’s stock, valued at approximately $4,531,000.

Other institutional investors have also modified their holdings of the company. Global Retirement Partners LLC grew its holdings in Addus HomeCare by 395.7% during the fourth quarter. Global Retirement Partners LLC now owns 233 shares of the company’s stock worth $25,000 after acquiring an additional 186 shares during the period. Larson Financial Group LLC boosted its position in shares of Addus HomeCare by 133.3% during the 3rd quarter. Larson Financial Group LLC now owns 238 shares of the company’s stock valued at $28,000 after purchasing an additional 136 shares in the last quarter. NFJ Investment Group LLC acquired a new position in shares of Addus HomeCare in the 2nd quarter worth approximately $29,000. Acumen Wealth Advisors LLC acquired a new stake in Addus HomeCare during the fourth quarter valued at approximately $29,000. Finally, Arax Advisory Partners lifted its stake in Addus HomeCare by 95.8% during the fourth quarter. Arax Advisory Partners now owns 280 shares of the company’s stock valued at $30,000 after purchasing an additional 137 shares during the last quarter. Institutional investors and hedge funds own 95.35% of the company’s stock.

Addus HomeCare Trading Up 0.4%

Addus HomeCare stock opened at $118.69 on Friday. Addus HomeCare Corporation has a 52 week low of $87.95 and a 52 week high of $124.43. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.69 and a current ratio of 1.69. The firm has a market capitalization of $2.22 billion, a price-to-earnings ratio of 20.82, a P/E/G ratio of 1.58 and a beta of 0.86. The company has a 50 day moving average price of $113.57 and a 200 day moving average price of $103.09.

Addus HomeCare (NASDAQ:ADUS) last announced its earnings results on Monday, August 3rd. The company reported $1.73 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.70 by $0.03. The company had revenue of $377.41 million for the quarter, compared to the consensus estimate of $376.24 million. Addus HomeCare had a net margin of 7.13% and a return on equity of 9.96%. The company’s revenue was up 8.0% on a year-over-year basis. During the same period in the previous year, the business earned $1.49 EPS. Research analysts forecast that Addus HomeCare Corporation will post 6.3 EPS for the current year.

Insider Buying and Selling at Addus HomeCare

In related news, insider Heather Dixon sold 288 shares of the company’s stock in a transaction on Monday, June 22nd. The stock was sold at an average price of $93.77, for a total transaction of $27,005.76. Following the transaction, the insider directly owned 44,371 shares of the company’s stock, valued at approximately $4,160,668.67. The trade was a 0.64% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 4.10% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have issued reports on ADUS. Royal Bank Of Canada lifted their price target on shares of Addus HomeCare from $130.00 to $134.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 5th. Citizens Jmp reissued a “market outperform” rating and set a $142.00 price objective on shares of Addus HomeCare in a research note on Monday, May 18th. Weiss Ratings upgraded Addus HomeCare from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, July 9th. Citigroup reaffirmed a “market outperform” rating on shares of Addus HomeCare in a report on Friday, July 24th. Finally, Barclays increased their price target on Addus HomeCare from $92.00 to $96.00 and gave the company an “underweight” rating in a research report on Wednesday, July 8th. One research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $128.86.

Addus HomeCare Company Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.